HOME › Research Insight › Major Players in the Women’s Health Diagnostics Market Pursue Strategies of Mergers, Acquisitions, Partnerships, Agreements, and Collaborations to Strength Their Position in the Market
Major Players in the Women’s Health Diagnostics Market Pursue Strategies of Mergers, Acquisitions, Partnerships, Agreements, and Collaborations to Strength Their Position in the Market
The global women’s health diagnostics market mainly includes medical device manufacturers and diagnostic assay providers. As women health diagnostics is a continuously growing market the focus of players lies currently on product development and upgradation. The global women health diagnostics solutions market is dominated by Siemens AG (Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), and Koninklijke Philips N.V. (Netherlands). Quest Diagnostics Inc. is among the leading players in the women health diagnostics market. The company offers a comprehensive product portfolio for woman’s health diagnostics. These solutions span across the areas of oncology, Sexually Transmitted Disease, urinary tract infection, HIV, pregnancy, and prenatal testing. The company has strategically enhanced its presence in the global women’s health diagnostics market by adopting a number of inorganic and organic growth strategies such as collaborations, product launches, and acquisitions.
Major players are increasingly focusing on product launches in order to increase their market share in women’s health diagnostic market. Quest Diagnostics Inc. (U.S.), a leading player in the women health diagnostics market, launched Qvantage, a test for predicting hereditary cancer risk. The company continuously strives to improve and enhance its existing portfolio by introducing new testing solutions. In May 2015, Quest Diagnostics launched QNatal Advanced, a new noninvasive prenatal screening service for detecting chromosomal abnormalities in certain high-risk pregnancies. This launch strengthened the company’s portfolio for prenatal screening. Similarly, Siemens AG (Germany), another leading player in this market is offering a wide range of products for imaging and laboratory diagnostics. The company has a robust diagnostics product portfolio which range from mammography systems to breast cancer, ovarian cancer, bone diseases, and women nutrition testing.
Hologic, Inc. (U.S.), a leading global healthcare and diagnostics company. The company offers women’s health diagnostic solutions in the field of breast health, bone health, and gynecological health and further focuses on new product launches in order to expand its product portfolio. In April 2016, the company launched the Affirm Prone Biopsy system, the first 2D/3D imaging-guided dedicated prone biopsy system. This enabled the company to cater to the unmet needs of its customers by providing minimally invasive breast biopsies for its patients. Moreover, Hologic collaborated with eight Scottish Health Boards and signed multi-year contracts for its ThinPrep Pap Test, one of the most widely used methods for cervical cancer screening. This helped the company to increase its market share in European countries.
On the other hand, F. Hoffmann-La Roche AG provides, a leading company in women’s health diagnostics market sells a wide range of diagnostic products including those for oncology, infections, and immunology. The company has strategically enhanced its presence in the global women’s health market by adopting a number of inorganic and organic growth strategies such as collaborations, product launches, acquisitions, and regulatory approvals. In August 2015, Roche acquired Kapa Biosystems (U.S.), a provider of genomic tools. This acquisition enabled Roche to develop a differentiated NGS portfolio that provided a complete genetic testing solution.
Majority of industry players adopted the strategy of new product launches, expansions, agreements, alliances, collaborations, and partnerships as major growth strategies to achieve growth in the global women’s health diagnostics market. These strategies helped companies to garner larger market shares and strengthen their customer base and production capacities.
Womens Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India